Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Xtant Medical Holdings, Inc. (XTNT : AMEX)
 
 • Company Description   
Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., is based in Belgrade, United States.

Number of Employees: 232

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.69 Daily Weekly Monthly
20 Day Moving Average: 79,586 shares
Shares Outstanding: 139.32 (millions)
Market Capitalization: $95.92 (millions)
Beta: -0.14
52 Week High: $0.83
52 Week Low: $0.33
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.92% 1.96%
12 Week 53.34% 28.98%
Year To Date 55.42% 45.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
664 CRUISER LANE
-
BELGRADE,MT 59714
USA		 ph: 406-388-0480
fax: 406-388-1354		 investorrelations@xtantmedical.com http://www.xtantmedical.com
 
 • General Corporate Information   
Officers
Sean E. Browne - Chief Executive Officer;President and Director
Stavros G. Vizirgianakis - Chair of the Board and Director
Mark A. Schallenberger - Chief Operations Officer
Scott C. Neils - Chief Financial Officer
John K. Bakewell - Director

Peer Information
Xtant Medical Holdings, Inc. (ABMD)
Xtant Medical Holdings, Inc. (DMDS)
Xtant Medical Holdings, Inc. (CPWY.)
Xtant Medical Holdings, Inc. (EQUR)
Xtant Medical Holdings, Inc. (ECIA)
Xtant Medical Holdings, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 98420P308
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 139.32
Most Recent Split Date: 2.00 (0.08:1)
Beta: -0.14
Market Capitalization: $95.92 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.18
Price/Cash Flow: -
Price / Sales: 0.78
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: 18.05%
vs. Previous Quarter: 4.41%
ROE
06/30/25 - -
03/31/25 - -27.01
12/31/24 - -36.28
ROA
06/30/25 - -
03/31/25 - -12.49
12/31/24 - -17.22
Current Ratio
06/30/25 - -
03/31/25 - 2.34
12/31/24 - 2.35
Quick Ratio
06/30/25 - -
03/31/25 - 1.03
12/31/24 - 1.00
Operating Margin
06/30/25 - -
03/31/25 - -9.81
12/31/24 - -14.03
Net Margin
06/30/25 - -
03/31/25 - -9.81
12/31/24 - -14.03
Pre-Tax Margin
06/30/25 - -
03/31/25 - -9.73
12/31/24 - -13.87
Book Value
06/30/25 - -
03/31/25 - 0.32
12/31/24 - 0.31
Inventory Turnover
06/30/25 - -
03/31/25 - 1.28
12/31/24 - 1.23
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.51
12/31/24 - 0.51
Debt-to-Capital
06/30/25 - -
03/31/25 - 33.60
12/31/24 - 33.95
 

Powered by Zacks Investment Research ©